| abstract |
The invention relates to the use of hemichannel inhibitors for modulating cytokine levels in a subject, including angiogenic cytokine, VEGF and their production, secretion and / or release, and the use of inhibitors. of hemichannels to reduce or stabilize the activity of the cytokine, including under conditions characterized in whole or in part by angiogenesis and / or vessel leakage. |